MER511
/ Merida Biosciences
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 09, 2026
NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease
(clinicaltrials.gov)
- P1 | N=100 | Recruiting | Sponsor: Merida Biosciences | Active, not recruiting ➔ Recruiting
Enrollment open • First-in-human • Endocrine Disorders • Grave’s Disease
1 to 1
Of
1
Go to page
1